PTPN1 splice variants could up-regulated JAK/STAT activity in classic Hodgkin lymphoma cells, accelerated tumor cell proliferation, and reduced the toxicity effect of chemotherapy drugs such as gessabine and oroposide (34, 35). The gene discussed is SOAT1; the disease is Hodgkins lymphoma.